Short answer: Algae oil is a vegetarian source of long-chain marine omega-3 fatty acids (EPA and DHA) derived from cultivated microalgal species, principally Schizochytrium sp. (the dominant commercial DHA source) and Crypthecodinium cohnii (Martek DHA). The microalgae are cultivated in controlled fermentation tanks, delivering the same EPA and DHA molecules found in fish oil but without marine-fishing trophic-level sourcing. Per Heinemann 2008 (J Anim Sci) canine algae DHA bioavailability study, algae-source DHA achieves equivalent canine plasma concentrations and red-cell membrane incorporation as fish-source DHA. Per Bauer 2008 (JAVMA) canine omega-3 review, algae oil is the only commercially viable vegetarian source of DHA — flaxseed and other plant-source omega-3 deliver ALA which dogs convert to EPA + DHA at less than 10% efficiency. The KibbleIQ rubric treats algae-source EPA + DHA equivalently to fish-source for omega-3 credit.

The microbiology — Schizochytrium and Crypthecodinium

Per Park 2010 (Mar Drugs) microalgal lipid review and the AAFCO 2024 ingredient definitions, two principal microalgal genera dominate commercial DHA production. Schizochytrium sp. is a marine protist (Thraustochytriaceae family) that natively produces high concentrations of DHA in its membrane lipids; commercial strains are cultivated in heterotrophic fermentation tanks (fed glucose, no light required) and harvested for DHA extraction. Crypthecodinium cohnii is a dinoflagellate-related marine protist used in the Martek DHA process originally developed for infant-formula DHA fortification.

The biosynthesis pathway in Schizochytrium uses the polyketide synthase (PKS) pathway rather than the conventional desaturase / elongase pathway used by most plants and animals per Metz 2001 (Science). The PKS pathway produces DHA directly without requiring sequential desaturation and elongation from precursor fatty acids, which is part of why these microalgae achieve such high DHA proportions (often 40–60% of total fatty acids). The commercial result is a high-DHA oil that can be incorporated into pet food, infant formula, or human supplements at gram-level inclusion rates.

Bauer 2008 framework — the only vegetarian DHA source

Per Bauer 2008 (JAVMA) canine omega-3 review and Bauer 2011 (J Anim Physiol Anim Nutr) follow-on synthesis, dogs convert dietary alpha-linolenic acid (ALA, the 18-carbon plant-source omega-3) to EPA and DHA at low efficiency. The conversion pathway requires delta-6 desaturase, elongase, and delta-5 desaturase activities sequentially; per Bauer 2008, the canine conversion efficiency from ALA to EPA is approximately 5–15%, and from EPA to DHA is approximately 0–5%. The net efficiency from dietary ALA to tissue DHA is therefore approximately 1–5% — well below the levels needed to support clinical omega-3 effects on the AAHA 2022 / Roush 2010 evidence base.

The conversion-efficiency limit means that plant-source omega-3 supplementation (flaxseed oil, perilla oil, chia oil) does not substitute for direct EPA + DHA supplementation in dogs — even at gram-level ALA intakes. Per Bauer 2011, dogs requiring EPA + DHA for clinical indication (canine osteoarthritis per AAHA 2022 / Roush 2010 JAVMA, cardiac support per ACVIM 2022 nutritional cardiomyopathy, skin-and-coat per AAHA 2024) must receive direct EPA + DHA from marine or microalgal sources. See our flaxseed oil explainer for the plant-source omega-3 context that informs why vegetarian DHA delivery requires algae oil specifically.

Sustainability and contaminant advantages over fish oil

Per AAHA 2022 omega-3 sourcing references and Park 2010 (Mar Drugs) sustainability review, algae oil has structural sourcing advantages over wild-harvested fish oil. Sustainability: microalgae are cultivated in closed-system fermentation tanks fed glucose or glycerol; no marine harvest is required. Wild-fish omega-3 sourcing depends on small-pelagic fisheries (anchovy, sardine, menhaden) that have variable harvest sustainability per FAO 2023 fisheries assessment; the MSC-certified and bycatch-managed sources are operationally constrained. Algae oil scales independently of fisheries.

Contaminant load: per Anker 2018 (J Funct Foods) algae omega-3 review, microalgae cultivated in closed-system fermentation tanks have negligible mercury, PCB, dioxin, and persistent organic pollutant load compared with marine fish that bioaccumulate these contaminants from environmental exposure. Wild-fish oil requires molecular distillation or ethyl-ester refining to reduce contaminant load to safe levels; algae oil arrives at the formulator without this processing step. The result is a cleaner ingredient at higher cost. See our omega-3 fatty acids explainer for the EPA / DHA clinical evidence framework that algae oil delivers equivalently to fish oil.

Pet-food formulation — oxidative stability and inclusion levels

Per Schuchardt 2011 (PLEFA) long-chain omega-3 oxidation review, algae-source DHA has the same oxidation susceptibility as fish-source DHA because the oxidation-vulnerable structure is the long-chain polyunsaturated fatty acid molecule itself, not the source species. Pet-food formulations including algae oil require the same natural-preservative protection as fish-oil-enriched formulations: mixed tocopherols (alpha + gamma per vitamin E forms explainer), ascorbic acid or ascorbyl palmitate (regenerating co-antioxidant), and rosemary extract + green tea extract (polyphenol synergists per rosemary extract explainer) at AAFCO 2024-permitted concentrations.

Typical pet-food inclusion levels for algae oil deliver EPA + DHA in the same milligram-per-kilogram-body-weight range as fish-oil supplementation per AAHA 2014 / 2022 / 2024 guidelines: 50–100 mg combined EPA + DHA per kg body weight per day for general health maintenance; 100–200 mg/kg/day for inflammatory or skin conditions per AAHA 2022 dermatology; 200–300 mg/kg/day for osteoarthritis per Roush 2010 JAVMA. Higher therapeutic doses are typically delivered through supplemental fish oil or algae oil rather than kibble-level inclusion. See our salmon oil explainer, krill oil explainer, and sardine oil explainer for the fish-source siblings that pair with algae oil in the omega-3 sourcing landscape.

How KibbleIQ scores algae oil

The KibbleIQ Dry Kibble Rubric treats algae-source EPA + DHA equivalently to fish-source EPA + DHA for omega-3 credit. The active molecules (EPA and DHA) are the same regardless of source; the sustainability and contaminant-load differential informs ingredient-quality narrative but does not change clinical efficacy per Heinemann 2008 J Anim Sci bioavailability data. The rubric awards omega-3 credit when algae oil, fish oil, salmon oil, krill oil, sardine oil, anchovy oil, or named-species marine oil delivers measurable EPA + DHA in the formulation.

The rubric’s strongest skin-and-coat / cardiac / joint-support tier combines algae oil or fish oil + mixed tocopherols + rosemary extract + omega-3-dose-appropriate inclusion (typically 0.5–1.0% combined EPA + DHA dry matter for clinical indication). Vegetarian and vegan-positioned formulations rely on algae oil as the only commercially viable DHA source. See best dog food for skin and coat for the broader omega-3 framework. To check your dog’s food, paste the ingredient list into the KibbleIQ analyzer.